Publicaciones en colaboración con investigadores/as de Hospital Universitario Marqués de Valdecilla (10)

2022

  1. The role of PSMA radioligands in the diagnosis and treatment of prostate carcinoma

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 41, Núm. 2, pp. 126-135

2021

  1. Early imaging and molecular changes with neoadjuvant bevacizumab in stage ii/iii breast cancer

    Cancers, Vol. 13, Núm. 14

2020

  1. FDG PET/CT in colorectal cancer

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 39, Núm. 1, pp. 57-66

  2. Preparation, radiolabeling with 99mTc and 67Ga and biodistribution studies of albumin nanoparticles covered with polymers

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 39, Núm. 4, pp. 225-232

2019

  1. 18F-FDG PET/CT in locally advanced cervical cancer: A review

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 38, Núm. 1, pp. 59-68

2018

  1. 68Ga-PSMA PET/CT in prostate cancer

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 37, Núm. 2, pp. 130-138

  2. Radium-223 in the treatment of bone metastasis in patients with castration-resistant prostate cancer. Review and procedure

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 37, Núm. 5, pp. 330-337

2017

  1. 18F-FDG PET/CT in breast cancer: Evidence-based recommendations in initial staging

    Tumor Biology, Vol. 39, Núm. 10, pp. 1-23

  2. 18F-fluorodeoxyglucose positron emission tomography in the diagnosis of malignancy in patients with paraneoplastic neurological syndrome: a systematic review and meta-analysis

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 44, Núm. 9, pp. 1575-1587

2012

  1. Expression of MALT1 oncogene in hematopoietic stem/progenitor cells recapitulates the pathogenesis of human lymphoma in mice

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 109, Núm. 26, pp. 10534-10539